LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Listă Acțiuni・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Deschisă

Sector Sănătate

1.63 -3.55

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.61

Maxim

1.69

Indicatori cheie
By Trading Economics
Venit	-51M
Vânzări	540K 702K
EPS	-0.2
Marjă de profit	-31,188.272
Angajați	285
EBITDA	-49M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+390 upside

Statistici piață
By TradingEconomics
Capitalizare de piață	-1.2M 510M
Deschiderea anterioară	5.18
Închiderea anterioară	1.63

Sentimentul știrilor

By Acuity

12%

88%

8 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

1.67 / 1.72 Suport & Rezistență

Lexicon Pharmaceuticals Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 mar. 2024, 12:57 UTC

Principalele dinamici ale pieței

Lexicon Pharmaceuticals Shares Rise on Beat to 4Q Loss, Plans for Sotagliflozin

Comparație

Modificare preț

Lexicon Pharmaceuticals Inc Așteptări

Obiectiv de preț

By TipRanks

390% sus

Prognoză pe 12 luni

Medie 8.33 USD 390%

Maxim 10 USD

Minim 5 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruLexicon Pharmaceuticals Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Lexicon Pharmaceuticals Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

1.67 / 1.72Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

8 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for human diseases. The Company's drug programs include Sotagliflozin, LX9211 and LX2761. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease. LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of sodium-glucose cotransporter 2 (SGLT2) in the kidney.